This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Michael Koch: Innovator in Neurodegenerative Disease Treatment
Introduction
Michael Koch is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neurodegenerative diseases. His innovative work has the potential to impact the lives of many individuals suffering from these conditions.
Latest Patents
Michael Koch holds a patent for "Substituted 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)thiophene-2-carboxamide derivatives and use thereof." This patent includes compounds that are useful for the treatment and prevention of neurodegenerative diseases, including ophthalmological neurodegenerative disorders. The disclosure also features compositions containing these compounds, as well as methods for their use and production. He has 1 patent to his name.
Career Highlights
Michael Koch is affiliated with Johns Hopkins University, where he continues to engage in groundbreaking research. His work is characterized by a commitment to advancing scientific knowledge and developing practical applications for his discoveries.
Collaborations
Throughout his career, Michael has collaborated with notable colleagues, including Brendan N Lilley and William Schubert. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Michael Koch's contributions to the field of neurodegenerative disease treatment exemplify the impact of innovative research in medicine. His work not only advances scientific understanding but also holds promise for improving patient outcomes.